Pandemic Highlights Need for Pharmacoequity

The pandemic continues to exacerbate racial disparities and to create new ones. “Race is not just foundational to the challenges of underinsurance and access but access to treatments, from monoclonal antibodies to antiviral therapies,” CP3's Dr. Utibe Essien told Vox.